Novartis Nears Completion of $600 Million Biomedical Research Institute Expansion in Cambridge, Massachusetts

SUGAR LAND--February 20, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Swiss drug giant Novartis AG (NYSE:NVS) (Basel, Switzerland) is nearing the end of construction on a $600 million expansion at its Institutes for Biomedical Research (NIBR) in Cambridge, Massachusetts.

Within this article: Details on Novartis' plans for the facility, including expected capacity and current schedules.